Статья

Patterns of the SARS-CoV-2 epidemic spread in a megacity [Закономерности эпидемического распространения SARS-CoV-2 в условиях мегаполиса]

V. Akimkin, S. Kuzin, T. Semenenko, O. Shipulina, S. Yatsyshina, E. Tivanova, A. Kalenskaya, I. Solovyova, M. Vershinina, O. Kvasova, A. Ploskireva, M. Mamoshina, M. Elkina, V. Klushkina, E. Andreeva, A. Ivanenko,
2021

The purpose of the study is to analyze patterns demonstrated by the COVID-19 epidemic process in a megacity during the increase, stabilization and reduction in the incidence, and to evaluate the effectiveness of the epidemic prevention measures. Materials and methods. The comprehensive study incorporating epidemiological, molecular-genetic and statistical research methods was conducted to analyze the spread of SARS-CoV-2 in Moscow during the COVID-19 pandemic. Results and discussion. It was found that the exponential growth in COVID-19 cases was prevented due to the most stringent control and restrictive measures deployed in Moscow to break the chains of SARS-CoV-2 transmission and due to people who were very disciplined in complying with the self-isolation rules. The analysis of the dynamics in detection of new COVID-19 cases showed that in a megacity, the impact of social distancing and self-isolation would become apparent only after 3.5 incubation periods, where the maximum length of the period is 14 days. It was discovered that the detection frequency of SARS-CoV-2 RNA in relatively healthy population and its dynamics are important monitoring parameters, especially during the increase and stabilization in the COVID-19 incidence, and are instrumental in predicting the development of the epidemic situation within a range of 1-2 incubation periods (14-28 days). In Moscow, the case fatality rate was 1.73% over the observation period (6/3/2020-23/6/2020). Conclusion. The epidemiological analysis of the COVID-19 situation in Moscow showed certain patterns of the SARS-CoV-2 spread and helped evaluate the effectiveness of the epidemic prevention measures aimed at breaking the routes of transmission of the pathogen. © 2020 Izdatel'stvo Meditsina. All rights reserved.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • V. Akimkin
    Central Research Institute for Epidemiology, Moscow, 197101, Russian Federation
  • S. Kuzin
    National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya, Moscow, 123098, Russian Federation
  • T. Semenenko
    Office of the Federal Service for Supervision of Consumer Rights Protection and Human Well-Being in Moscow, Moscow, 129626, Russian Federation
  • O. Shipulina
    Center for Hygiene and Epidemiology in the City of Moscow, Moscow, 129626, Russian Federation
  • S. Yatsyshina
  • E. Tivanova
  • A. Kalenskaya
  • I. Solovyova
  • M. Vershinina
  • O. Kvasova
  • A. Ploskireva
  • M. Mamoshina
  • M. Elkina
  • V. Klushkina
  • E. Andreeva
  • A. Ivanenko
Название журнала
  • Voprosy Virusologii
Том
  • 65
Выпуск
  • 4
Страницы
  • 203-211
Ключевые слова
  • virus RNA; Article; case fatality rate; clinical effectiveness; clinical evaluation; clinical observation; coronavirus disease 2019; epidemic; home quarantine; human; incidence; incubation time; infection prevention; microbial population dynamics; molecular epidemiology; molecular genetics; nonhuman; pandemic; pollution monitoring; practice guideline; Russian Federation; Severe acute respiratory syndrome coronavirus 2; social distancing; virus detection; virus transmission; diagnosis; epidemiology; female; genetics; male; mortality; COVID-19; COVID-19 Nucleic Acid Testing; Epidemics; Female; Humans; Male; Moscow; SARS-CoV-2
Издатель
  • FBSI Central Research Institute of Epidemiology of Rospotrebnadzor
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus